MSAM
ABCL icon

Moloney Securities Asset Management’s AbCellera Biologics ABCL Stock Holding History

Moloney Securities Asset Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$60.4K Hold
12,000
– – 0.01% 476
2025
Q2 		$41.2K Sell
12,000
-2,400
-17% -$5.97K 0.01% 475
2025
Q1 		$32.1K Sell
14,400
-76,000
-84% -$218K ﹤0.01% 466
2024
Q4 		$265K Buy
+90,400
New +$252K 0.04% 368
2022
Q3 		– Sell
-15,800
Closed -$168K – 380
2022
Q2 		$168K Buy
+15,800
New +$134K 0.04% 341
2022
Q1 		– Sell
-13,100
Closed -$187K – 414
2021
Q4 		$187K Sell
13,100
-9,000
-41% -$137K 0.03% 411
2021
Q3 		$443K Buy
22,100
+11,200
+103% +$198K 0.08% 262
2021
Q2 		$240K Sell
10,900
-20,050
-65% -$553K 0.04% 360
2021
Q1 		$1.05M Buy
+30,950
New +$1.23M 0.21% 130

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return